Trial Profile
Pharmacokinetics, safety, and tolerability of edoxaban in patients with end-stage renal disease undergoing haemodialysis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary)
- Indications Stroke; Thromboembolism
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 03 Nov 2015 New trial record